Stem Cell Clinic

Novelion Announces Court Approval for Interim Distribution to Registered Shareholders

By Global News Feed

VANCOUVER, British Columbia, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (“Novelion” or the “Company”) by Alvarez & Marsal Canada Inc., Novelion’s court appointed liquidator (the “Liquidator”) today announces its intention to make an interim distribution to its registered shareholders in January 2021 (the “Interim Distribution”). The Interim Distribution will be made pursuant to an Order of the Supreme Court of British Columbia (the “Court”) dated December 16, 2020 in accordance with the Company’s Liquidation Plan. The mechanics of the Interim Distribution are in the process of being finalized and the date of the Interim Distribution will be communicated to the Company’s shareholders by way of a subsequent press release once confirmed.

See the original post here:
Novelion Announces Court Approval for Interim Distribution to Registered Shareholders

Medcolcanna Organics Inc. Announces Closing of Upsized Convertible Debenture Financing

By Global News Feed

BOGOTÁ, Colombia, Dec. 24, 2020 (GLOBE NEWSWIRE) -- Medcolcanna Organics Inc. (“Medcolcanna”, “MCCN” or the “Company”) (NEO: MCCN), a leading Colombian and globally integrated cannabis company, is pleased to announce that it has closed on the second and final tranche of its previously announced offering of convertible debentures as per the press release dated August 28, 2020, raising gross aggregate proceeds of $0.25 million, bringing the total amount raised pursuant to this offering to $1.25 million, being the full amount previously disclosed. The offering consists of convertible secured debentures (the “Debentures”). The Debentures are convertible into common shares in the capital of the Company (“Common Shares”) on the following terms: the Debentures are issuable in $1,000 increments and are convertible into Common Shares at a price of $0.20 per share (meaning 5,000 shares may be issued on the conversion of each Debenture) and will have a term of two (2) years from the date of issuance, with interest payable twice yearly of fourteen percent (14%) per annum (simple not compounded), payable in cash or shares. The Debentures will be subject to earlier redemption by the Company in the event the Common Shares are trading on the facilities of the Neo Exchange Inc. (or such other stock exchange on which the Common Shares may then be trading) at a volume weighted average trading price at or above $0.40 per share for a period of not less than ten (10) consecutive trading days.

Follow this link:
Medcolcanna Organics Inc. Announces Closing of Upsized Convertible Debenture Financing

BioStem Technologies, Announces Filing of 2020 Quarterly Reports

By Global News Feed

Pompano Beach, Fl, Dec. 24, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading life sciences company specializing in perinatal tissue allografts for use in regenerative therapies, today announced that it has filed its quarterly reports for 2020 to become current with OTC Markets.

The rest is here:
BioStem Technologies, Announces Filing of 2020 Quarterly Reports

Global Neural Stem Cells Market 2020-2026 updated Report with the latest scenarios based on the global COVID-19 Pandemic – Farming Sector

By Stell Cell Research

Global Neural Stem Cells Market Forecast 2026- Research Report(Download Free Sample) discusses the demand, gross margin, sales, and market share of the Neural Stem Cells Industry. The growth drivers, trends, and developments in the Neural Stem Cells industry are explained. The Neural Stem Cells Report presents the company profiles of top market players, with a complete analysis of production, revenue share, price structures, and gross margin analysis from 2015-2019. Also, the Neural Stem Cells markets served and the geographical presence of these top players is explained in detail.

The report begins with the Neural Stem Cells Market overview, scope, market size estimation, and growth rate by Neural Stem Cells Product type. Also, top Applications in Neural Stem Cells Market are studied in this report. The next segment analyzes the capacity, production, pricing structures, and market trends from 2015-2026. The top Neural Stem Cells Industry trends and market driving forces with the analysis of market risks are studied.

Request A Free Sample Report Here: https://globalmarketers.biz/report/life-sciences/global-neural-stem-cells-market-report-2020-by-key-players,-types,-applications,-countries,-market-size,-forecast-to-2026-(based-on-2020-covid-19-worldwide-spread)/158606#request_sample

Leading Players List:

Cellular Dynamics International Stemedica Cell Technologies Inc Fibrocell Science Inc Corestem Inc, Corning Inc. Celgene Corporation Kangstem Biotech Ltd Ge Healthcare Biotime Inc Thermo Fisher Vericel Corporation Cellular Engineering Technologies Inc Brainstorm Cell Therapeutics Cytori Therapeutics Becton Dickinson Takara Holdings Inc.

The latest product launch events, mergers & acquisitions in Neural Stem Cells, and expansion plans are listed. The geographical regions/countries namely United States, Europe, China, Japan, South Korea, India, Southeast Asia, and the rest. Further, regional regional bifurcation includes the Neural Stem Cells market presence in the countries namely United States, Canada, Mexico, UK, Italy, Russia, France, Germany, Australia, Thailand, Indonesia, Vietnam, Philippines, Brazil, Central & South America, and Middle East & Africa. In the Middle East & Africa, the top countries analyzed are Egypt, South Africa, and the Gulf countries.

The christmas and Year-End Sale is on Live on selected Reports. Ask For Discount :https://globalmarketers.biz/discount_inquiry/discount/158606

Global Neural Stem Cells Market segments:

Global Neural Stem Cells Market By Type:

Neural Crest Stem Cell(NC-SC) CNS Stem Cells(CNS-SC)

Global Neural Stem Cells Market By Application:

Neurodevelopmental Repair damaged nerve tissue Others

In the next segment, Neural Stem Cells Market value chain and sales channel analysis are conducted to present information on upstream suppliers and downstream buyers. The opportunities and challenges in Neural Stem Cells Market and factors affecting the market growth are analyzed in depth. The forecast Neural Stem Cells Market analysis explains the growth rate, consumption, capacity, and expected revenue analysis. Lastly, data sources, research methodology, and analyst views are explained.

Research Methodology: The Global Neural Stem Cells Market Report is formulated by using top-down and bottom-up research methodology. The global market is fragmented into segments to provide regional and country-level analysis. Numerous surveys and detailed primary research is conducted to present Neural Stem Cells Market estimation, applications, and growth. The Neural Stem Cells market scope is analyzed across different geographies. Detailed mapping of major Neural Stem Cells manufacturers, applications, and product types is conducted for analyzing potential clients. The annual Neural Stem Cells Market revenue is calculated from annual reports, paid primary interviews, and secondary data sources.

Inquiry Before Purchasehttps://globalmarketers.biz/report/life-sciences/global-neural-stem-cells-market-report-2020-by-key-players,-types,-applications,-countries,-market-size,-forecast-to-2026-(based-on-2020-covid-19-worldwide-spread)/158606#inquiry_before_buying

The key developments in Neural Stem Cells Industry, company overview, SWOT analysis, and market drivers are estimated to offer Neural Stem CellsMarket overview. The most crucial part of Neural Stem Cells Report which is a competitive vendor landscape profile offers a detailed performance of top players and their growth trends. Also, the business tactics and strategies implement by major Neural Stem Cells Industry players are profiled in this study. Our research study will help the renowned and emerging Neural Stem Cells Market players to understand industry competition and development aspects.

Global Neural Stem Cells Market Research Report Serves The Following Purpose: To state the Neural Stem Cells sales price, revenue, market share, size, and value from 2015-2019 and 2020-2026 To study top Neural Stem Cells Market players and analyze their geographical presence, competitive profile, and gross margin analysis. To analyze the Neural Stem Cells market scope across top regions namely North America, Europe, Asia-Pacific, Middle East & Africa, Central & South America, and rest of the world. To present mergers & acquisitions, expansion plans, future scope, and development status. To present SWOT analysis, Neural Stem Cells market drivers, threats, and risk assessment. The complete evaluation of pricing structure, stakeholders, manufacturers, dealers, traders, and distributors is conducted. To study forecasts Neural Stem Cells Industry prospects like market value, volume, consumption, and regional scope from 2020-2026. Valuable data sources, research methodology, analyst views, and suggestions are offered.

Review the Complete TOC: https://globalmarketers.biz/report/life-sciences/global-neural-stem-cells-market-report-2020-by-key-players,-types,-applications,-countries,-market-size,-forecast-to-2026-(based-on-2020-covid-19-worldwide-spread)/158606#table_of_contents

Originally posted here:
Global Neural Stem Cells Market 2020-2026 updated Report with the latest scenarios based on the global COVID-19 Pandemic - Farming Sector

→←